Search
Search
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
图: 1 / 1
Bezafibrate is a fibric acid derivative used primarily as an antihyperlipidemic agent. It functions as an agonist for all three peroxisome proliferator-activated receptor (PPAR) subtypes: PPAR-alpha, PPAR-gamma, and PPAR-delta. Activation of PPAR-alpha by bezafibrate leads to reduced triglyceride levels, while PPAR-gamma activation results in insulin sensitization and enhanced glucose metabolism. PPAR-delta activation promotes fatty acid metabolism. Bezafibrate's role in regulating lipid homeostasis, inflammation, cell differentiation, and proliferation has been studied in various contexts, including its hepatic antifibrotic effects. The drug's chemical structure is characterized by a chlorobenzoylamino-ethyl-phenoxy-methylpropionic acid moiety, which contributes to its lipid-regulating properties.
仅用于科研。不用于诊断过程。未经明确授权不得转售。